Next Article in Journal
Adiponectin, A-FABP and FGF-19 Levels in Women with Early Diagnosed Gestational Diabetes
Next Article in Special Issue
Chronic Pelvic Pain in Endometriosis: Cross-Sectional Associations with Mental Disorders, Sexual Dysfunctions and Childhood Maltreatment
Previous Article in Journal
References Values of Soluble α-Klotho Serum Levels Using an Enzyme-Linked Immunosorbent Assay in Healthy Adults Aged 18–85 Years
Previous Article in Special Issue
Endometriosis, an Ongoing Pain—Step-by-Step Treatment
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Evaluation of Women’s Age and Ultrasonographic Features to Choose Surgical Treatment for Endometriosis Associated with Ovarian Cancer

1
Department of Obstetrics and Gynecology, Hospital Universitario La Paz, Paseo de la Castellana, 261, 28046 Madrid, Spain
2
Department of Obstetrics and Gynecology, Faculty of Medicine, Universidad Autónoma de Madrid, C/Arzobispo Morcillo 2, 28029 Madrid, Spain
3
Department of Orthopaedic Surgery and Traumatology, Hospital Universitario La Paz, Paseo de la Castellana, 261, 28046 Madrid, Spain
4
Division of Gynecology and Human Reproduction Physiopathology, Department of Medical and Surgical Sciences (DIMEC), IRCCS Azienda Ospedaliero, S. Orsola Hospital, University of Bologna, Via Masserenti 13, 40138 Bologna, Italy
5
Department of Physiology, Faculty of Medicine, Universidad Autónoma de Madrid, C/Arzobispo Morcillo 2, 28029 Madrid, Spain
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
J. Clin. Med. 2022, 11(9), 2414; https://doi.org/10.3390/jcm11092414
Submission received: 11 March 2022 / Revised: 8 April 2022 / Accepted: 24 April 2022 / Published: 25 April 2022
(This article belongs to the Special Issue Endometriosis: Current Perspectives on Diagnosis and Treatment)

Abstract

Adequate surgical management of malignant endometriosis remains a clinical challenge in gynecology. Age, sonography variables, and tumor biomarkers have been reported as candidates in the clinical decision. This study aims were to analyze the factors of women’s age, body mass index, ultrasound features, and tumor biomarkers to predict endometriosis-associated ovarian cancer in a large series of endometriomas and to study the surgical treatment performed in this cohort. In this retrospective study, we reviewed the medical records of patients with ultrasound diagnosis of ovarian cyst classified as endometrioma (benign as well as with risk of malignancy), surgically treated in the endometriosis unit of Hospital Universitario La Paz (Madrid, Spain) between January 2019 and July 2021. According to the final histology examination, the women were clustered as non-endometriosis-associated ovarian cancer (OE, benign endometriomas, n = 59) and endometriosis-associated ovarian cancer (EAOC) (n = 17). Demographic, clinical, and surgical data were collected from these women. International Ovarian Tumor Analysis (IOTA) criteria were assessed for the ultrasound examination. The age of the women in the EAOC group was 50.0 [43.0; 63.0] years, which was significantly higher than OE (39.0 [34.0; 46.0] years; p-value < 0.001). In addition, the body mass index for the OE group (24.9 ± 5.3 kg/m2) was significantly higher than for the EAOC group (23.3 ± 4.6 kg/m2; p-value < 0.001). However, the tumor biomarker levels (CA 125, CA 19.9 and He4) were not significantly different among the groups. We performed 51.4% cystectomies and 48.6% adnexectomies, with an association between the adnexectomy and EAOC group (p-value < 0.001). In addition, a significant association was found between ultrasound features suspicious for malignancy and the EAOC group. Conclusively, women’s age and ultrasound features, such as papillary projections, septa, and positive echo-Doppler, were the main factors to consider when evaluating the malignancy risk associated with endometriosis.
Keywords: ovarian cancer; endometriosis-associated ovarian cancer; CA 125; ultrasound; risk factor ovarian cancer; endometriosis-associated ovarian cancer; CA 125; ultrasound; risk factor

Share and Cite

MDPI and ACS Style

Hernández, A.; Sanz, A.; Spagnolo, E.; Carbonell, M.; Rodríguez, E.; López, A.; Raganato, R.; Del Forno, S.; Ramiro-Cortijo, D. Evaluation of Women’s Age and Ultrasonographic Features to Choose Surgical Treatment for Endometriosis Associated with Ovarian Cancer. J. Clin. Med. 2022, 11, 2414. https://doi.org/10.3390/jcm11092414

AMA Style

Hernández A, Sanz A, Spagnolo E, Carbonell M, Rodríguez E, López A, Raganato R, Del Forno S, Ramiro-Cortijo D. Evaluation of Women’s Age and Ultrasonographic Features to Choose Surgical Treatment for Endometriosis Associated with Ovarian Cancer. Journal of Clinical Medicine. 2022; 11(9):2414. https://doi.org/10.3390/jcm11092414

Chicago/Turabian Style

Hernández, Alicia, Angela Sanz, Emanuela Spagnolo, María Carbonell, Elena Rodríguez, Ana López, Riccardo Raganato, Simona Del Forno, and David Ramiro-Cortijo. 2022. "Evaluation of Women’s Age and Ultrasonographic Features to Choose Surgical Treatment for Endometriosis Associated with Ovarian Cancer" Journal of Clinical Medicine 11, no. 9: 2414. https://doi.org/10.3390/jcm11092414

APA Style

Hernández, A., Sanz, A., Spagnolo, E., Carbonell, M., Rodríguez, E., López, A., Raganato, R., Del Forno, S., & Ramiro-Cortijo, D. (2022). Evaluation of Women’s Age and Ultrasonographic Features to Choose Surgical Treatment for Endometriosis Associated with Ovarian Cancer. Journal of Clinical Medicine, 11(9), 2414. https://doi.org/10.3390/jcm11092414

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop